Dublin, July 27, 2022 (GLOBE NEWSWIRE) -- The "Emerging Singlecell Technology Startups 2022" report has been added to ResearchAndMarkets.com's offering.

The global single-cell technology (SCT) market has emerged since the mid-2010s. The SCT is defined as any cell biology research tool that provides single cell resolution handling and data sets, for example, single cell (SC) picking up/dispensing, SC-sequencing, and SC-protein analysis technologies.

There are +58 commercial SCT products from 52 companies and over 30 pre-commerce-stage startups to enter the market in the next few years. Primarily, the SCT market is young and complex: over 75% of the products were launched within the last 7 years by startups and characterized by its wide range of technology mixtures and various types of users. The key topics in the emerging biotech research tool market are the integration of phenotypic-genotype in one device/assay, AI-powered data analysis, spatial omics analysis, and enhanced attention to cell therapy and precision medicine markets.

The report identified and analyzed the 38 early- pre-commercial stage SCT startups, and segmented them by their functional applications: new cell sorter, SC-isolation, SC-sequencing, screening/cell to cell interaction, data analysis (software), and spatial omics analysis. Each market segment was analyzed by its technical advantages. For each startup, we present the company profile, technology description, and target market applications.

Key Topics Covered:

Introduction

Part 1. Global Single-Cell Technology (SCT) market overview

Part 2. Emerging startups by functional category

SCE company presentation

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/4o4hj3